Szabó I, Penyige A, Barabás G, Szabó G, Dinya Z
Institute of Biology, University Medical School, Debrecen, Hungary.
Antimicrob Agents Chemother. 1989 Jan;33(1):58-62. doi: 10.1128/AAC.33.1.58.
A compound (compound X) with antibacterial activity was isolated from early-exponential-phase cultures of the streptomycin producer Streptomyces griseus and from protoplast cultures of the same strain. The protoplast cultures produced a larger amount of compound X than did the young hyphae. Both the mycelia and the protoplasts incorporated 14C-labeled myo-inositol, a precursor of streptomycin, into compound X, which has an amino acid content related to that of the cell wall peptidoglycan of the producer strain. Compound X may contain a streptomycin molecule covalently bound to a cell wall precursor unit, i.e., to a Park nucleotide (J. T. Park, J. Biol. Chem. 194:897-904, 1952), through the glutamic acid of the pentapeptide component.
一种具有抗菌活性的化合物(化合物X)从链霉素产生菌灰色链霉菌的指数生长早期培养物以及同一菌株的原生质体培养物中分离得到。原生质体培养物产生的化合物X比年轻菌丝体产生的量更多。菌丝体和原生质体都将14C标记的肌醇(链霉素的前体)掺入到化合物X中,化合物X的氨基酸含量与产生菌菌株细胞壁肽聚糖的氨基酸含量相关。化合物X可能包含一个通过五肽组分的谷氨酸与细胞壁前体单元(即帕克核苷酸,J. T. 帕克,《生物化学杂志》194:897 - 904, 1952)共价结合的链霉素分子。